Becton, Dickinson and Company (NYSE:BDX) Q2 2024 Earnings Conference Call May 2, 2024 8:00 AM ET
Company Participants
Greg Rodetis - Senior Vice President, Treasurer, and Head of Investor Relations
Tom Polen - Chairman, Chief Executive Officer, and President
Chris DelOrefice - Executive Vice President, and Chief Financial Officer
Mike Garrison - President of the Medical Segment
Dave Hickey - President of the Life Sciences Segment
Rick Byrd - President of the Interventional Segment
Conference Call Participants
Travis Steed - Bank of America
Robbie Marcus - J.P. Morgan
Vijay Kumar - Evercore ISI
Larry Biegelsen - Wells Fargo
Matthew Taylor - Jefferies
Matthew Miksic - Barclays Capital
Operator
Hello, and welcome to BD's Second Fiscal Quarter 2024 Earnings Call. At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com, or by phone at 1800-723-5792 for domestic calls, and area code +1 402-220-2664 for international calls. For today's call, all parties have been placed in a listen-only mode until the question-and-answer session.
I will now turn the call over to Greg Rodetis, Senior Vice President, Treasurer, and Head of Investor Relations.
Greg Rodetis
Good morning, and welcome to BD's earnings call. I'm Greg Rodetis, Senior Vice President, Treasurer, and Head of Investor Relations. Thank you for joining us. This call is being made available via audio webcast at bd.com. Earlier this morning, BD released its results for the second quarter of fiscal 2024. The press release and presentation can be accessed on the IR website at investors.bd.com.
Leading today's calls are Tom Polen, BD's Chairman, Chief Executive Officer, and President; and Chris DelOrefice, Executive Vice President, and Chief Financial Officer. Following this morning's prepared remarks, Tom and Chris will be joined for Q&A by our Segment Presidents, Mike Garrison, President of the Medical Segment; Dave Hickey, President of the Life Sciences Segment; and Rick Byrd, President of the Interventional Segment.
Before we get started, I want to remind you that we will be making forward-looking statements. You could read the disclaimer in our earnings release and the disclosures in our SEC filings, available on the Investor Relations website. Unless otherwise specified, all comparisons will be made on a year-over-year basis versus the relevant fiscal period. Revenue percentage changes are on an FX-neutral basis unless otherwise noted. Reconciliations between GAAP and non-GAAP measures are included in the appendices of the earnings release and presentation.